Morningstar
•
Nov 06, 2026
Humana Inc.: Humana Earnings: Decelerating Utilization Trends Boost 2026 Outlook Slightly
Summary
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Market Update: CAKE, COP, DGX, EMR, GPN, HON, MSI, YUM, VRSK
Nov 06, 2026
•
YUM, MSI, DGX, GPN, COP, HON, CAKE, EMR, VRSK
Analyst Report: Quest Diagnostics Inc
Nov 06, 2026
•
DGX
Analyst Report: Becton, Dickinson and Company
Nov 06, 2026
•
BDX
Analyst Report: DaVita Inc.
Nov 06, 2026
•
DVA
Analyst Report: The Cigna Group
Nov 05, 2026
•
CI
Analyst Profile
Julie Utterback
Senior Analyst
Julie Utterback is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers life sciences firms in the healthcare industry.Utterback initially joined Morningstar in 2005 as an equity analyst in the healthcare industry. At that time, she covered medical technology companies, including orthopedic device, medical equipment, and cardiac device firms. In 2010, she joined Morningstar's credit research team, initiating coverage on the entire healthcare industry and generally helping the organization expand and maintain its credit coverage across many industries. She held that senior credit analyst role until rejoining the equity team in April 2019.Prior to joining Morningstar, Utterback was an equity analyst at State Farm Insurance for several years. She holds a bachelor's degree in finance from the University of Illinois Urbana- Champaign. She also holds the Chartered Financial Analyst® designation.
